A prospective study of macrophage migration inhibitory factor as a marker of inflammatory detection

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 4077-4083

  Zhang, Chao ^a,b   Hou, Guihua ^a   Liang, Ting ^b   Song, Jing ^b   Qu, Lili ^b   Chen, Fuqiang ^b   Xu, Jia ^b   Wang, Dan ^b   Han, Jiankui ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Anti MIF McAb; IgG; Immunohistochemistry; Inflammation; Radioiodine; RT PCR; Storage phosphor screen

Indexed keywords

IMMUNOGLOBULIN G; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CHEMISTRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; METABOLISM; METHODOLOGY; MOUSE; PATHOLOGY; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; WHOLE BODY IMAGING;

ANIMALS; ANTIBODIES, MONOCLONAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, INBRED BALB C; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; WHOLE BODY IMAGING;

MUS;

EID: 77449129422     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00537.x     Document Type: Article

References (33)

1. Okarvi SM. Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases. Med Res Rev. 2004, 24:357-97.
2. Richard JC, Chen DL, Ferkol T. Molecular imaging for pediatric lung diseases. Pediatr Pulmonol. 2004, 37:286-96.
3. Staab EV, McCartney WH. Role of 67Gallium in inflammatory disease. Semin Nucl Med 1978, 8:219-34.
4. Seabold JE, Palestro CJ, Brown ML. Procedure guideline for gallium scintigraphy in inflammation. Society of Nuclear Medicine. J Nucl Med. 1997, 38:994-7.
5. Seabold JE, Forstrom LA, Schauwecker DS. Procedure guideline for indium-111-leukocyte scintigraphy for suspected infection/inflammation. Society of Nuclear Medicine. J Nucl Med. 1997, 38:997-1001.
6. De Schrijver M, Streule K, Senekowitsch R. Scintigraphy of inflammation with nanometer-sized colloidal tracers. Nucl Med Commun. 1987, 8:895-908.
7. Buscombe JR, Miller RF, Lui D. Combined 67Ga citrate and 99Tcm-human immunoglobulin imaging in human immunodeficiency virus-positive patients with fever of undetermined origin. Nucl Med Commun. 1991, 12:583-92.
8. McAfee JG, Gagne G, Subramanian G. The localization of indium-111-leukocytes, gallium-67-polyclonal IgG and other radioactive agents in acute focal inflammatory lesions. J Nucl Med. 1991, 32:2126-31.
9. Donnelly SC, Haslett C, Reid PT. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med. 1997, 3:320-3.
10. Bernhagen J, Calandra T, Mitchell RA. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature. 1993, 365:756-9.
11. Bernhagen J, Mitchell RA, Calandra T. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry. 1994, 33:14144-55.
12. Kleemann R, Hausser A, Geiger G. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature. 2000, 408:211-6.
13. Bucala R. Signal transduction. A most interesting factor. Nature. 2000, 408:146-7.
14. Calandra T, Spiegel LA, Metz CN. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Natl Acad Sci USA. 1998, 95:11383-8.
15. Calandra T, Echtenacher B, Roy DL. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med. 2000, 6:164-70.
16. Mikulowska A, Metz CN, Bucala R. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol. 1997, 158:5514-7.
17. Leech M, Metz C, Santos L. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum. 1998, 41:910-7.
18. Bernhagen J, Bacher M, Calandra T. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med. 1996, 183:277-82.
19. Lan HY, Mu W, Yang N. De novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol. 1996, 149:1119-27.
20. Rossi AG, Haslett C, Hirani N. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Invest 1998, 101:2869-74.
21. Makita H, Nishimura M, Miyamoto K. Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation. Am J Respir Crit Care Med. 1998, 158:573-9.
22. Hoi AY, Morand EF, Leech M. Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus. Immunol Cell Biol. 2003, 81:367-73.
23. Kobayashi S, Nishihira J, Watanabe S. Prevention of lethal acute hepatic failure by antimacrophage migration inhibitory factor antibody in mice treated with bacille Calmette-Guerin and lipopolysaccharide. Hepatology 1999, 29:1752-9.
24. Zhang C, Hou GH, Han JK. Radioiodine labeled anti-MIF McAb: a potential agent for inflammation imaging. Mediators Inflamm. 2007, 2007:50180.
25. Rennen HJ, Boerman OC, Oyen WJ. Imaging infection/inflammation in the new millennium. Eur J Nucl Med. 2001, 28:241-52.
26. Becker W, Goldenberg DM, Wolf F. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions. Semin Nucl Med. 1994, 24:142-53.
27. Visser GW, Klok RP, Gebbinck JW. Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN. J Nucl Med. 2001, 42:509-19.
28. Jayson GC, Zweit J, Jackson A. Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies. J Natl Cancer Inst. 2002, 94:1484-93.
29. Verel I, Visser GW, Boellaard R. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice. J Nucl Med. 2003, 44:1663-70.
30. Datz FL, Anderson CE, Ahluwalia R. The efficacy of indium-111-polyclonal IgG for the detection of infection and inflammation. J Nucl Med. 1994, 35:74-83.
31. Abrams MJ, Juweid M, tenKate CI. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med. 1990, 31:2022-8.
32. Calame W, Feitsma HI, Ensing GJ. Detection of a local staphylococcal infection in mice with technetium-99m-labeled polyclonal human immunoglobulin. J Nucl Med. 1991, 32:468-74.
33. Bucala R, Donnelly SC. Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity. 2007, 26:281-5.